Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology

• Lassa fever in Nigeria: epidemiology and risk perception. (November 12, 2024)
• Epidemiology of Lassa Fever and Factors Associated with Deaths, Bauchi State, Nigeria, 2015–2018. (April, 2020)
• Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis.  (October, 2019)

Clinical Information and Management

• Lassa fever research priorities: towards effective medical countermeasures by the end of the decade. (November, 2024)
• Pathological Insights into Lassa Virus-Induced Vestibular Dysfunction in Mice: Histopathological Analysis of the Inner Ear Vestibular Apparatus. (October 21, 2024)
• Lassa Virus Infection: a Summary for Clinicians. (June, 2022)
• One-Year Retrospective Review of Psychiatric Consultations in Lassa Fever, Southern Nigeria. (December, 2020)
• Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018. (January, 2019)
• Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. (June 1, 2018)
• Lassa fever. (July 12, 2017)

Antiviral Treatment

• Environmental Persistence and Disinfection of Lassa Virus. (November, 2023)
• Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults. (October 31, 2022)
• Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria. (July 26, 2022)
• Use of Favipiravir to Treat Lassa Virus Infection in Macaques. (September, 2018)
• Predicting outcome and improving treatment for Lassa fever. (June, 2018)
• Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever. (June 22, 2017)

Vaccination

• Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial. (April 15, 2023)
• Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. (October 6, 2022)